[HIV wasting syndrome].
Osoegawa
M
M
Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University.
Kira
J
J
D023241:Antiretroviral Therapy, Highly Active; D003937:Diagnosis, Differential; D013006:Growth Hormone / Q000627:therapeutic use; D019247:HIV Wasting Syndrome / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D019290:Megestrol Acetate / Q000627:therapeutic use; D018529:Nutritional Support; D013739:Testosterone / Q000627:therapeutic use; D013792:Thalidomide / Q000627:therapeutic use
D013739:Testosterone; D013792:Thalidomide; D013006:Growth Hormone; D019290:Megestrol Acetate